The role of the medial head of the gastrocnemius myocutaneous flap transfer in the management of prosthesis exposure and deep joint infection following total knee arthroplasty Authors: Sen Li, Xiuping Xu Published: 2024 ABSTRACT AbstractBackgroundThere is a lack of effective and innovative treatment for patients with prosthesis exposure and deep joint infection following total knee arthroplasty. This study explores the application of the medial head of the gastrocnemius myocutaneous flap transfer in these conditions, offering new therapeutic strategies for clinical practice.MethodsClinical data of 68 patients with prosthesis exposure and deep joint infection following total knee arthroplasty were included and retrospectively analyzed. Patients were divided into one study group (n = 35, received medial head of the gastrocnemius myocutaneous flap transfer and vacuum sealing drainage) and one control group (n = 33, received vacuum sealing drainage). The total effective rates, visual analogue scale (VAS), Hospital for Special Surgery score (HSS), knee joint function, activity, inflammatory reactions, safety, and recurrence rate were compared between the two groups.ResultsThe total effective rate in the study group was higher than that in the control group. VAS scores in the study group were lower at 3 and 7 days after treatment. HSS scores were higher in the study group after treatment. The study group showed lower levels of hs-CRP and IL-6 after treatment. At 1 month and 3 months after treatment, the study group exhibited higher knee joint activity. There was no difference in the incidence of adverse reactions between the two groups, and the study group had a lower recurrence rate.ConclusionMedial head of the gastrocnemius myocutaneous flap transfer effectively improves knee joint function and activity, reduces pain, alleviates inflammatory reactions, and has fewer adverse reactions and a lower recurrence rate.Keywords: Total knee arthroplasty, Medial head of the gastrocnemius myocutaneous flap transfer, Prosthesis exposure, Deep joint infection, Vacuum sealing drainage Introduction With the exacerbation of the global aging trend, knee joint pain and functional impairments caused by bone and joint diseases, arthritis, and related issues are increasingly prominent among the elderly population. Consequently, total knee arthroplasty has become one of the primary methods for addressing these issues [1]. Despite continuous advancements in surgical techniques, the procedure is still associated with potential complications, among which prosthesis exposure and deep joint infection are particularly severe [2]. According to a retrospective study [3], 9 patients (6%) experienced poor wound healing following total knee arthroplasty, whereas, after implementing improved therapeutic strategies, only 1 patient (0.75%) suffered from poor wound healing. Additionally, reports have indicated that the rate of deep joint infection after total knee arthroplasty is approximately 1-2% [4]. Once an infection occurs, the presence of the prosthesis directly increases the difficulty of infection control. Failure to address this in a timely manner can lead to catastrophic consequences such as prosthesis removal, joint fusion, or even amputation. Therefore, early selection of appropriate treatment plays a crucial role in eradicating infections and salvaging the prosthesis. Previously, clinicians often opted for vacuum sealing drainage (VSD), primarily achieved through continuous or intermittent negative pressure suction on the wound using an externally connected suction device, until the infection is completely controlled before wound closure. This method can effectively drain exudates from the wound at any time, decrease the bacterial load in the infected wound, inhibit bacterial growth and reproduction, and thereby prevent toxin absorption and infection spread [5, 6]. Furthermore, this approach promotes wound recovery and cavity closure, while reducing wound area. However, during the negative pressure suction process, there is a significant risk of increased bleeding at the surgical site, leading to hematoma formation. Improper operation can also escalate the severity of infection [7, 8]. As clinical research progresses, some scholars have proposed that the medial head of the gastrocnemius myocutaneous flap can reduce the risk of infection and promote proper healing [9]. Other reports have indicated that the medial head of the gastrocnemius myocutaneous flap is a primary method for reconstructing soft tissues following exposed total knee arthroplasty [10]. Meanwhile, the transfer of the medial head of the gastrocnemius myocutaneous flap effectively addresses tissue defects caused by prosthesis exposure or infection, promotes wound healing, optimizes blood supply at the site of infection through the flap’s circulatory properties, and aids in infection control. The rich blood supply and excellent tissue compatibility of the medial head of the gastrocnemius myocutaneous flap help expedite postoperative wound healing and infection control, while the muscle flap’s elasticity and strength provide adequate soft tissue coverage, protecting the joint prosthesis and preventing further exposure. However, the current clinical literature on the treatment of prosthesis exposure and deep joint infection following total knee arthroplasty using this method is limited. This paper aims to gain a deeper understanding of the advantages and limitations of the medial head of the gastrocnemius myocutaneous flap transfer in treating prosthesis exposure and deep joint infection after total knee arthroplasty. Materials and methods General information A total of 68 patients who underwent total knee arthroplasty and subsequently developed prosthesis exposure and deep joint infection between February 2020 and February 2023 at our institution was selected. Clinical data for all patients, including age, gender, body mass index, disease duration, primary illness, etc., were collected and retrospectively analyzed. The patients were divided into a study group (n = 35, undergoing medial head of the gastrocnemius myocutaneous flap transfer) and a control group (n = 33, undergoing vacuum sealing drainage). Inclusion criteria: (1) All patients experienced prosthesis exposure and deep joint infection following total knee arthroplasty at our institution; (2) Diagnosis confirmed through knee joint X-rays and magnetic resonance imaging; (3) First-time treatment; (4) Informed consent obtained from the patients and their families. Exclusion criteria: (1) Presence of lower limb vascular disorders, liver or kidney dysfunction, or mental illness; (2) Contraindications for surgery or anesthesia; (3) Presence of severe knee stiffness or significant varus or valgus deformity. Treatment methods Control Group: The control group underwent vacuum sealing drainage, involving the removal of necrotic tissue and inflammatory synovium from the joint. Subsequently, a thorough examination of the prosthesis was conducted, and upon confirming stability, irrigation was carried out using iodophor (Anhui Tianyang Pharmaceutical Co., Ltd., China Food and Drug Administration Approval Number H34022817, 5%) and hydrogen peroxide (Nanchang Baiyun Pharmaceutical Co., Ltd., China Food and Drug Administration Approval Number H36021594, 100 ml:3 g). Additionally, joint immersion in iodophor was performed. A VSD sponge was placed inside the joint cavity, connected to continuous negative pressure suction, while intermittent irrigation with physiological saline (Anhui Fengyuan Pharmaceutical Co., Ltd., China Food and Drug Administration Approval Number H20103227, 500 ml) was done through the VSD device at a rate of 3000 ml/d. After 7 days, drainage fluid was cultured, and if results showed positivity, wound debridement was performed, and continuous negative pressure suction through VSD was replaced. Study Group: In addition to the above procedures, the study group underwent medial head of the gastrocnemius myocutaneous flap transfer. This involved a longitudinal incision along the midline of the patient’s calf, through the skin and superficial and deep fascia. The incision was made at the junction of the medial and lateral heads of the gastrocnemius muscle, followed by separation of the gastrocnemius muscle from the soleus muscle, from distal to proximal, to the pedicle, cutting its attachment to the femoral condyle, and freeing the medial gastrocnemius artery and vein to enhance the flap’s mobility range. After releasing the tourniquet, the fascial grid on the flap’s surface was incised to expand and enlarge the flap. The flap was raised and transferred through a subcutaneous tunnel to the knee joint defect and sutured and fixed to the membranes on both sides of the subcutaneous tunnel to prevent tension on the pedicle vessels. The flap was wrapped around the prosthesis, inserted into the joint cavity, and the distal end of the flap was sutured and fixed to the joint capsule, while the surrounding area and the incision were sutured. Any exposed areas of the flap were covered with split-thickness skin grafts for direct closure. Observational index Evaluation of the Overall Efficacy Rate at 3 months After Treatment: Remarkable effectiveness refers to complete infection control, normalized body temperature, complete wound healing, absence of recurrent exposure signs, substantial restoration of joint function meeting daily life requirements. Effective embodies partial infection control, temperature normalization, partially healed wound, reduced exposed area, improved joint function which has not yet fully recovered. Ineffectiveness denotes uncontrolled deep-seated infection, sustained abnormal body temperature, unhealed or poorly healing wounds, unchanged or enlarged exposed area, no significant improvement in joint function, or even deterioration. The overall effectiveness rate is calculated as the sum of remarkable effectiveness and effectiveness rate. Evaluation of the Overall Efficacy Rate at 3 months After Treatment: Remarkable effectiveness refers to complete infection control, normalized body temperature, complete wound healing, absence of recurrent exposure signs, substantial restoration of joint function meeting daily life requirements. Effective embodies partial infection control, temperature normalization, partially healed wound, reduced exposed area, improved joint function which has not yet fully recovered. Ineffectiveness denotes uncontrolled deep-seated infection, sustained abnormal body temperature, unhealed or poorly healing wounds, unchanged or enlarged exposed area, no significant improvement in joint function, or even deterioration. The overall effectiveness rate is calculated as the sum of remarkable effectiveness and effectiveness rate. Evaluation of Visual Analog Scale (VAS) at Baseline, 3 days, and 7 days After Treatment: [11] The VAS is a commonly used pain assessment tool, involving a 10 cm horizontal line on paper, with one end representing no pain (scored as 0) and the other indicating severe pain (scored as 10), and various degrees of pain represented in between. The scale demonstrates a Cronbach’s α coefficient of 0.881, test-retest reliability of 0.855, content validity of 0.871, thus ensuring good scale reliability and validity. Evaluation of Visual Analog Scale (VAS) at Baseline, 3 days, and 7 days After Treatment: [11] The VAS is a commonly used pain assessment tool, involving a 10 cm horizontal line on paper, with one end representing no pain (scored as 0) and the other indicating severe pain (scored as 10), and various degrees of pain represented in between. The scale demonstrates a Cronbach’s α coefficient of 0.881, test-retest reliability of 0.855, content validity of 0.871, thus ensuring good scale reliability and validity. Assessment of Knee Joint Function Score (Hospital for Special Surgery, HSS) at Baseline and 3 months After Treatment: [12] The HSS is a scale widely employed to evaluate the severity of knee joint disease, encompassing aspects such as joint stability, functional activities, muscle strength, and knee flexion deformity, with different scoring criteria for each item. Scores range from 0 to 100, with > 85 indicating excellent knee joint function, 70–84 representing fair function, 60–69 indicating moderate impairment, and < 59 indicating severe functional impairment. The scale exhibits a Cronbach’s α coefficient of 0.862, test-retest reliability of 0.834, content validity of 0.812, reflecting robust scale reliability and validity. Assessment of Knee Joint Function Score (Hospital for Special Surgery, HSS) at Baseline and 3 months After Treatment: [12] The HSS is a scale widely employed to evaluate the severity of knee joint disease, encompassing aspects such as joint stability, functional activities, muscle strength, and knee flexion deformity, with different scoring criteria for each item. Scores range from 0 to 100, with > 85 indicating excellent knee joint function, 70–84 representing fair function, 60–69 indicating moderate impairment, and < 59 indicating severe functional impairment. The scale exhibits a Cronbach’s α coefficient of 0.862, test-retest reliability of 0.834, content validity of 0.812, reflecting robust scale reliability and validity. Measurement of Hypersensitive C-reactive Protein (hs-CRP) and Interleukin-6 (IL-6) Levels at Baseline and 24 h After Treatment: Blood samples were collected from patients’ fasting peripheral veins (4 ml), centrifuged at 4000 rpm for 5 min, and the serum was tested using enzyme-linked immunosorbent assay kits purchased from Roche. Measurement of Hypersensitive C-reactive Protein (hs-CRP) and Interleukin-6 (IL-6) Levels at Baseline and 24 h After Treatment: Blood samples were collected from patients’ fasting peripheral veins (4 ml), centrifuged at 4000 rpm for 5 min, and the serum was tested using enzyme-linked immunosorbent assay kits purchased from Roche. Assessment of Knee Joint Mobility at Baseline, 7 days, 1 month and 3 months After Treatment: Measurement of knee joint mobility was conducted using a wearable joint motion measurement device (Beijing Yimai Technology Co., Ltd., Model QD-I, Jingxie Zhu Jun 20182070410). Assessment of Knee Joint Mobility at Baseline, 7 days, 1 month and 3 months After Treatment: Measurement of knee joint mobility was conducted using a wearable joint motion measurement device (Beijing Yimai Technology Co., Ltd., Model QD-I, Jingxie Zhu Jun 20182070410). Statistical analysis of adverse reaction incidence and recurrence rate within 3-months post-treatment for all groups. Statistical analysis of adverse reaction incidence and recurrence rate within 3-months post-treatment for all groups. Statistics process The study utilized SPSS 29.0 statistical software (SPSS Inc., Chicago, IL, USA) for data analysis. Categorical data were expressed as [n (%)] and were subjected to chi-square tests. For sample sizes ≥ 40 and theoretical frequencies (T) ≥ 5, the standard chi-square test was applied, denoted by χ2. In cases where the sample size was ≥ 40 but the theoretical frequency was between 1 and 5, an adjusted chi-square test using a correction formula was used. However, for sample sizes < 40 or theoretical frequencies less than 1, Fisher’s exact probability method was employed for statistical analysis. Normality of continuous variables was evaluated using the Shapiro-Wilk method. When data were normally distributed, the format (Mean ± sd) was utilized, whereas non-normally distributed data underwent analysis using the Wilcoxon rank-sum test, and were presented as median (25% quantile, 75% quantile). A P-value less than 0.05 was considered statistically significant. Results Comparison of Basic Information between the two groups Both groups showed no significant differences in clinical data (including age, gender, body mass index, course of disease, and primary disease) (all P > 0.05), as shown in Table 1. And the case photos of knee prosthesis exposure and deep joint infection in two groups of patients are shown in Fig. 1. Table 1Comparison of Basic Information between the Two GroupsGroupAge [years]Gender (M/F)Body Mass Index [kg/m2]Duration of Illness [months]Underlying Disease (Traumatic Arthritis/Knee Osteoarthritis/Rheumatoid Arthritis)Study Group (n = 35)64.52 ± 2.4814 (40.00%) / 21 (60.00%)22.91 ± 1.093.62 ± 0.589 (25.71%)/13 (37.14%)/13 (37.14%)Control Group (n = 33)64.87 ± 1.8417 (51.52%) / 16 (48.48%)23.34 ± 0.963.81 ± 0.798 (24.24%)/15 (45.45%)/10 (30.3%)χ2/Z0.6560.9081.7291.1580.535 P 0.5140.3410.0890.2510.765 Comparison of Basic Information between the Two Groups The case photos of knee prosthesis exposure and deep joint infection in two groups (A: Study Group; B: Control Group)of patients Comparison of total efficacy rates between the two groups The total efficacy rate is used to evaluate the postoperative treatment effects on prosthesis expoure and deep joint infection. As shown in Table 2., the study group exhibited a higher total efficacy rate compared to the control group (91.43% vs. 60.61%, χ2 = 8.968, P = 0.003). The study results indicate a higher total efficacy rate in the study group. Table 2Comparison of total effective rate between the two groups [n(%)]GroupRemarkable effectivenessEffectiveIneffectivenessOverall effectivenessStudy Group (n = 35)1616332 (91.43%)Control Group (n = 33)8121320 (60.61%) χ 2 8.968 P 0.003 Comparison of total effective rate between the two groups [n(%)] Comparison of VAS scores at different time points The VAS was used to assess pain levels at different time points. As depicted in Table 3, the pre-treatment VAS scores were comparable between the two groups, whereas at 3 days post-treatment, the study group exhibited lower scores (4.35 ± 1.21 vs. 5.21 ± 1.73, P = 0.022), and at 7 days post-treatment, the study group demonstrated lower scores (2.61 ± 0.77 vs. 3.07 ± 1.02, P = 0.038). The study results indicate a significant reduction in pain levels in the study group. Table 3Comparison of VAS scores at different time pointsGroupBefore Treatment3 days after Treatment7 days after TreatmentStudy Group (n = 35)6.12 ± 1.944.35 ± 1.212.61 ± 0.77Control Group (n = 33)6.34 ± 2.035.21 ± 1.733.07 ± 1.02 t 0.4612.3482.115 P 0.6460.0220.038 Comparison of VAS scores at different time points Comparison of changes in HSS scores between the two groups HSS scores were used to evaluate joint function recovery after total knee arthroplasty. As shown in Table 4, the pre-treatment HSS scores were comparable between the two groups, yet post-treatment, the study group exhibited higher scores (88.26 ± 7.45 vs. 80.77 ± 6.39, P < 0.001). The study results indicate better joint function recovery in the study group. Table 4Changes in HSS scores in the two groupsGroupBefore TreatmentAfter Treatmentt P Study Group (n = 35)63.58 ± 7.4288.26 ± 7.4513.886<0.001Control Group (n = 33)64.11 ± 7.1180.77 ± 6.3910.011<0.001 t 0.2994.441 P 0.766< 0.001 Changes in HSS scores in the two groups Comparison of inflammatory markers between the two groups hs-CRP, a protein marker that appears during acute inflammatory response, and IL-6, a cytokine of the chemokine family, reflect the inflammatory status of patients. As depicted in Table 5, the pre-treatment values for inflammatory markers were comparable between the two groups; post-treatment, the study group showed lower hs-CRP (38.96 ± 4.57 µg/ml vs. 67.16 ± 5.27 µg/ml, P < 0.001) and lower IL-6 (102.30 ± 10.31pg/ml vs. 207.97 ± 20.28pg/ml, P < 0.001). The study results indicate a significant reduction in inflammatory response in the study group. Table 5Comparison of inflammatory markers between the two groupsGrouphs-CRP(µg/ml)IL-6(pg/ml)Before TreatmentAfter TreatmentBefore TreatmentAfter TreatmentStudy Group (n = 35)9.33 ± 1.2738.96 ± 4.5712.56 ± 2.54102.30 ± 10.31Control Group (n = 33)9.45 ± 1.1367.16 ± 5.2711.97 ± 2.11207.97 ± 20.28 t 0.40123.6171.03326.846 P 0.689< 0.0010.305< 0.001 Comparison of inflammatory markers between the two groups Comparison of knee joint mobility between the two groups Knee joint mobility refers to the rotational angle produced during joint movement. As presented in Table 6, the knee joint mobility at baseline and at 7 days post-treatment was comparable between the two groups; however, at 1-month post-treatment, the study group showed higher mobility (112.36 ± 8.54 vs. 105.79 ± 8.11, P = 0.002). Similarly, the study group showed higher mobility after three months of treatment (118.36 ± 9.17 vs. 109.24 ± 7.44, P < 0.001). The study results indicate a noticeable improvement in knee joint mobility in the study group. Table 6Comparison of knee joint mobility in the two groups(± sd)GroupBefore Treatment7 days after Treatment1 month after Treatment3 months after TreatmentStudy Group (n = 35)88.23 ± 5.21101.54 ± 7.39112.36 ± 8.54118.36 ± 9.17Control Group (n = 33)90.12 ± 5.67100.83 ± 7.06105.79 ± 8.11109.24 ± 7.44 t 1.4300.4033.2474.487 P 0.1570.6880.002< 0.001 Comparison of knee joint mobility in the two groups(± sd) Comparison of adverse reaction rates and recurrence rates between the two groups Adverse reaction rates are used to evaluate treatment safety, whereas recurrence rates assess the long-term effects and stability of treatment. As shown in Table 7, the incidence of adverse reactions was comparable between the two groups, yet the study group exhibited a lower recurrence rate (14.29% vs. 42.42%, χ2 = 6.680, P = 0.010). The study results indicate a higher total efficacy rate in the study group. Table 7Comparison of adverse reactions and recurrence rates in the two groups [n(%)]GroupSkin NecrosisBleedingAdverse ReactionsRecurrence RateStudy Group (n = 35)224 (11.43%)5 (14.29%)Control Group (n = 33)336 (18.18%)14 (42.42%) χ 2 0.1976.680 P 0.6580.010 Comparison of adverse reactions and recurrence rates in the two groups [n(%)] Discussion Despite being widely regarded as a success story in modern medicine, approximately 20% of knee arthroplasty patients express dissatisfaction with the postoperative outcomes [13]. Prosthesis exposure and deep joint infection are common and severe postoperative complications following total knee arthroplasty. Prosthesis exposure refers to the partial or complete exposure of the artificial prosthesis at the knee joint replacement site outside the skin or tissue due to certain reasons closely related to surgical operation, such as excessively thick or sharp prosthesis placement, shallow surgical clearance, or impact on the prosthesis postoperatively, which can directly exacerbate pain, significantly impacting daily life [14, 15]. On the other hand, deep joint infection typically occurs in the joint space or in the deep tissues surrounding the prosthesis, primarily propagated from superficial infections or dissemination from distant infectious foci through the bloodstream, lymphatic vessels, etc. Untreated, it can lead to functional impairment, swelling, pain, and deformities, posing significant health risks to patients [16, 17]. This illustrates the importance of promptly selecting an appropriate treatment plan for improving patient prognosis. Clinical studies have found that the pedicled medial gastrocnemius muscle flap transposition surgery significantly benefits patients with prosthesis exposure and deep knee joint infections after total knee arthroplasty [18]. In this study, through the intervention of pedicled medial gastrocnemius muscle flap transposition, it was observed that the two groups had no difference in the incidence of adverse reactions (P > 0.05), but the study group exhibited a higher total efficacy rate and a lower recurrence rate (P < 0.05). The pedicled medial gastrocnemius muscle flap transposition not only covers and fills the exposed prosthesis area but also provides sufficient tissue and blood supply to promote wound healing, reduce infection risk, and expedite repair of the prosthesis-exposed area [19]. Furthermore, as the preferred method for soft tissue reconstruction, the pedicled medial gastrocnemius muscle flap offers rich blood supply, good infection resistance, and its leukocytes and other immune cells effectively combat infections, alleviate the severity of deep joint infections. Additionally, the muscle flap demonstrates good compatibility with the surrounding tissue, forming a stable bond, thereby reducing the risk of recurrence [20]. In comparison, although vacuum sealing drainage (VSD) can draw and expel exudates and bacteria through negative pressure, covering the wound and improving local blood circulation and nutrition, its repair capabilities are relatively limited. It cannot provide adequate tissue support and may face issues of tissue compatibility and stability in handling complex wounds, thus increasing the risk of recurrence [21]. In a previous report [22], approximately 15–20% of patients expressed dissatisfaction with persistent knee pain following total knee arthroplasty, and postoperative complications such as infection and prosthesis loosening cannot be overlooked. Deep joint infection is a significant cause of failure in total knee arthroplasty, often leading to inflammation within the joint space, resulting in symptoms such as joint swelling, pain, redness, and heat [23]. Additionally, postoperative infection may lead to other complications such as prosthesis loosening, ligament damage, which can also cause pain. In this study, it was observed that the VAS scores of the study group were significantly lower at 3- and 7-days post-treatment (P < 0.05). Generally, the pedicled medial gastrocnemius muscle flap transposition can provide immediate tissue coverage and repair. By employing the pedicled medial gastrocnemius muscle flap transposition to the affected area, it can rapidly fill and cover the exposed prosthesis and infected sites, thereby restoring joint integrity and reducing external stimulation, thus alleviating pain [24]. However, VSD primarily focuses on wound drainage and cleansing, with limited effectiveness in improving joint stability. Therefore, compared to the pedicled medial gastrocnemius muscle flap transposition, VSD has a lesser effect on alleviating patient pain. hs-CRP, a protein that elevates during inflammatory responses, is commonly used to monitor the extent and progression of inflammation. Following total knee arthroplasty, the levels of hs-CRP often increase if there is prosthesis exposure or deep joint infection due to the presence of inflammatory responses [25, 26]. IL-6, as an important inflammatory mediator, also plays a significant role in the postoperative inflammatory response following total knee arthroplasty. Studies have indicated that serum IL-6 levels continue to rise in patients with postoperative infection after total knee arthroplasty [27]. Therefore, this indicator serves as a new infection marker to assess the early level of inflammatory response in the body and aids in clinical judgment of postoperative infection in patients. The results of this study revealed that the post-treatment hs-CRP and IL-6 levels in the study group were lower (P < 0.05), further confirming the effectiveness of the pedicled medial gastrocnemius muscle flap transposition in controlling the body’s inflammatory response. As the pedicled medial gastrocnemius muscle flap transposition provides immediate tissue coverage and repair, it significantly reduces bacterial propagation at the infection site and the persistence of inflammatory reactions, consequently reducing the production of hs-CRP and IL-6 [28]. Furthermore, good blood supply not only provides essential nutrients and oxygen, but also aids in clearing inflammatory products and necrotic tissues. Additionally, the improvement in joint stability helps reduce mechanical pressure and friction within the joint, ultimately lowering the levels of inflammatory response and inflammatory mediators. Following deep joint infection postoperatively, patients may develop purulent drainage and inflammatory substances within the joint cavity, exacerbating knee pain and severely restricting normal knee joint function, leading to a noticeable reduction in knee joint mobility [29]. Moreover, prosthesis exposure can undermine joint stability and integrity, resulting in impaired joint function and even causing inflammation and adhesions in the surrounding soft tissues, further limiting the range of joint movement. Timely treatment is crucial based on these findings. The results of this study showed that the study group had higher HSS scores and higher knee joint mobility after treatment (P < 0.05). The pedicled medial gastrocnemius muscle flap transposition not only helps reduce the risk of infection, but also promotes joint wound healing, reduces adhesions and scar formation, restores the muscle strength around the joint, and enhances joint stability. Therefore, patients’ knee joint mobility and joint function can be better preserved and restored [30]. Additionally, patients receiving treatment with pedicled medial gastrocnemius muscle flap transposition experience a significant reduction in pain through infection and inflammation control, which provides a premise for rapid joint rehabilitation exercises and functional training, exerting a positive influence on the recovery of joint mobility and function. However, this study still has certain limitations. For instance, the sample size of this research may limit the generalizability and accuracy of the results. Additionally, the follow-up period may be relatively short, insufficient to evaluate the long-term effects of pedicled medial gastrocnemius muscle flap transposition, as recovery after total knee arthroplasty is a long-term process, requiring longer follow-up periods to observe the durability of treatment outcomes. Therefore, aside from the treatment of prosthesis exposure and deep joint infection following total knee arthroplasty, exploration can be conducted on the application of pedicled medial gastrocnemius muscle flap transposition in other areas, such as treating complications after other joint replacement surgeries. Furthermore, larger-scale studies should be pursued to further validate the effectiveness of this technique. Conclusion In conclusion, for patients who have undergone total knee arthroplasty and subsequently experienced prosthesis exposure and deep joint infections, the use of medial gastrocnemius muscle flap transfer demonstrates significant therapeutic benefits. This approach effectively improves knee joint function and mobility, rapidly alleviates pain, and promotes a reduction in inflammatory responses. Additionally, the procedure is associated with minimal adverse reactions and a low recurrence rate, making it a safe and effective option for clinical treatment. Acknowledgements The authors are grateful to all participants in the present study. Author contributions All authors contributed to the study conception and design. Material preparation, data collection and analysis were performed by Sen Li and Xiuping Xu. The first draft of the manuscript was written by Sen Li and Xiuping Xu commented on previous versions of the manuscript. All authors read and approved the final manuscript. Funding This study was not supported by any sponsor or funder. Data availability The data involved in the present study can be provided under reasonable request. Declarations Ethical approval The experimental protocol was approved by the Ethic Committee of Gansu Provincial Hospital of TCM (No. 2024-063-01), in line with the principles of the Declaration of Helsinki. Consent to participate The authors declare that there is no conflict of interest. Consent for publication Not applicable. Conflict of interest Not applicable. Footnotes Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Sen Li and Xiuping Xu contributed equally to this work. References Associated Data Data Availability Statement The data involved in the present study can be provided under reasonable request.